Pulmonx (LUNG)
(Delayed Data from NSDQ)
$7.44 USD
-0.04 (-0.53%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $7.45 +0.01 (0.13%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum C VGM
Balance Sheet
Fiscal Year End for Pulmonx Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 117 | 141 | 180 | 232 | 28 |
Receivables | 12 | 9 | 7 | 4 | 6 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 17 | 15 | 16 | 11 | 6 |
Other Current Assets | 4 | 4 | 5 | 3 | 2 |
Total Current Assets | 150 | 169 | 208 | 250 | 41 |
Net Property & Equipment | 4 | 5 | 5 | 1 | 1 |
Investments & Advances | 17 | 11 | 11 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 2 |
Intangibles | 2 | 2 | 3 | 3 | 3 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 1 |
Total Assets | 178 | 194 | 235 | 264 | 54 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 2 | 2 | 1 | 3 |
Current Portion Long-Term Debt | 2 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 16 | 13 | 13 | 9 | 9 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 1 |
Total Current Liabilities | 23 | 18 | 18 | 13 | 14 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 35 | 17 | 17 | 17 | 15 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 1 | 1 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 59 | 40 | 42 | 38 | 36 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 205 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 527 | 503 | 483 | 467 | 22 |
Retained Earnings | -411 | -350 | -291 | -243 | -211 |
Other Equity | 3 | 2 | 2 | 2 | 1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 118 | 154 | 193 | 226 | 18 |
Total Liabilities & Shareholder's Equity | 178 | 194 | 235 | 264 | 54 |
Total Common Equity | 118 | 154 | 193 | 226 | -187 |
Shares Outstanding | 38.30 | 37.40 | 36.80 | 35.60 | NA |
Book Value Per Share | 3.09 | 4.12 | 5.25 | 6.35 | 0.00 |
Fiscal Year End for Pulmonx Corporation falls in the month of December.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 115 | 116 | 117 | 117 | 136 |
Receivables | 11 | 11 | 12 | 10 | 9 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 17 | 17 | 17 | 16 | 16 |
Other Current Assets | 3 | 4 | 4 | 4 | 4 |
Total Current Assets | 146 | 148 | 150 | 147 | 164 |
Net Property & Equipment | 3 | 4 | 4 | 4 | 4 |
Investments & Advances | 2 | 7 | 17 | 27 | 17 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 2 | 2 | 2 | 2 | 2 |
Deposits & Other Assets | 1 | 1 | 1 | 0 | 0 |
Total Assets | 173 | 165 | 178 | 185 | 193 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3 | 3 | 2 | 3 | 2 |
Current Portion Long-Term Debt | 0 | 5 | 2 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 12 | 10 | 16 | 14 | 14 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 16 | 21 | 23 | 20 | 20 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 37 | 32 | 35 | 37 | 37 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 71 | 54 | 59 | 59 | 59 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 539 | 533 | 527 | 521 | 514 |
Retained Earnings | -440 | -425 | -411 | -397 | -382 |
Other Equity | 2 | 2 | 3 | 2 | 2 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 101 | 111 | 118 | 126 | 134 |
Total Liabilities & Shareholder's Equity | 173 | 165 | 178 | 185 | 193 |
Total Common Equity | 101 | 111 | 118 | 126 | 134 |
Shares Outstanding | 38.80 | 38.50 | 38.30 | 38.00 | 37.70 |
Book Value Per Share | 2.61 | 2.87 | 3.09 | 3.31 | 3.55 |